🇺🇸 CARBAMAZEPINE in United States

19,505 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 3,490 reports (17.89%)
  2. Drug Interaction — 2,434 reports (12.48%)
  3. Toxicity To Various Agents — 2,270 reports (11.64%)
  4. Seizure — 1,977 reports (10.14%)
  5. Fall — 1,882 reports (9.65%)
  6. Off Label Use — 1,772 reports (9.08%)
  7. Dizziness — 1,518 reports (7.78%)
  8. Fatigue — 1,394 reports (7.15%)
  9. Pain — 1,387 reports (7.11%)
  10. Pyrexia — 1,381 reports (7.08%)

Source database →

CARBAMAZEPINE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CARBAMAZEPINE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for CARBAMAZEPINE in United States?

Marketing authorisation holder not available in our data.